한국제약바이오협회는 지난 26일 서울 방배동 협회 회관에서 건강보험심사평가원과 국민건강 증진 및 국내 제약산업 발전을 위한 양해각서(MOU)를 체결했다고 27일 밝혔다.
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on the 27th that it signed a memorandum of understanding (MOU) with the Health Insurance Review and Assessment Service for the promotion of national health and the development of the pharmaceutical industry in Korea at the association's hall in Bangbae-dong, Seoul, on the 26th.